CN Stock MarketDetailed Quotes

600535 Tasly Pharmaceutical Group

Watchlist
  • 16.15
  • +1.15+7.67%
Market Closed Sep 30 15:00 CST
24.13BMarket Cap23.51P/E (TTM)

Tasly Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Tasly Pharmaceutical Group Q2 2024 Earnings Date

Currency：CNYAug 24, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
2.54B
2.32B
-217.92M
Miss Est.
--
+0.68%
-8.58%
Net Income
--
360.00M
--
-15.42%
Analyst Rating
Strong Buy

Oct 3, 2024

Tasly Pharmaceutical Group Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Aug 24, 20242024/Q22.323B / 2.541B--
--2024/Q12.049B / 2.208B--
--2023/Q42.103B / 2.709B--
--2021/Q11.764B / 1.589B--
--2020/Q42.185B / 1.519B--
DatePeriodRevenue/EstimateEarnings Call
Aug 24, 20242024/Q22.323B / 2.541B--
--2024/Q12.049B / 2.208B--
--2023/Q42.103B / 2.709B--
--2021/Q11.764B / 1.589B--
--2020/Q42.185B / 1.519B--

Unlock Free Earnings Estimates

Tasly Pharmaceutical Group Earnings Reports

  • tasly pharmaceutical group 2024 interim report

    Aug 24 00:00

  • Summary of Tasly Pharmaceutical Group's 2024 Interim Report

    Aug 24 00:00

  • Tasly 2024 First Quarter Report

    Apr 26 00:00

  • Tasly 2023 Annual Report

    Apr 16 00:00

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 3, 2024

    Strong Buy

    • Strong Buy

      75.00%

    • Buy

      25.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data